Clinical and Translational Science Institute (CTSI)
Drug & Device Development Seminar:
Speaker: Charles Wilson, Ph.D.
VP and Global Head, Strategic Alliances, Novartis Institutes for BioMedical Research
Cambridge, Massachusetts
“Partnering With Industry: How To Do It And What Does Industry Want”
Tuesday, February 21st
12 – 1 p.m.
650 Albany Street, 7th Floor, room 714
(Lunch will be provided)
The Boston University CTSI is pleased to announce a series of seminars that explore Drug and Device Development. The seminars are open to BU doctoral students, post-docs and faculty. Speakers have extensive experience in turning bench and other academic science discoveries into marketable products that effectively treat disease.
For questions, please contact Nilsa Carrasquillo at ncarras@bu.edu.
……………………………………………………………………………………………………………………………………………………………….
The Clinical and Translational Science Institute (CTSI) is offering an:
Open Study Design and Statistical Analysis Consultation
Wednesday, February 8, noon-1 p.m.
Location: L107
For those who are planning or who are currently conducting clinical or translational research, an open consultation session, sponsored by the Clinical and Translational Science Institute (CTSI), will be held on study design and statistical analysis. Meet with Howard Cabral from the Department of Biostatistics at the School of Public Health. Please contact him at hjcab@bu.edu with questions.
……………………………………………………………………………………………………………………………………………………………….
Boston University’s Clinical and Translational Science Institute (BU CTSI) connects scientists and clinicians to each other and to resources and information that can help their research. BU CTSI has been nicknamed the “BU Bridge” because it acts as a bridge between the Boston University health campus and the surrounding community, and strengthens existing partnerships with Boston’s community health centers. Its goal: to translate discoveries into therapies and cures more quickly and effectively, from lab bench to patient bedside and back.
